TRxADE HEALTH, Inc. (MEDS)
NASDAQ: MEDS · IEX Real-Time Price · USD
6.45
-0.05 (-0.77%)
At close: Apr 24, 2024, 3:59 PM
6.42
-0.03 (-0.47%)
After-hours: Apr 24, 2024, 4:00 PM EDT
Company Description
TRxADE HEALTH, Inc. operates as a health services IT company in the United States.
The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement.
It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name.
The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021.
TRxADE HEALTH, Inc. is based in Lutz, Florida.
TRxADE HEALTH, Inc.
| Country | United States |
| IPO Date | Feb 13, 2020 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 33 |
| CEO | Surendra K. Ajjarapu |
Contact Details
Address: 2420 Brunello Trace Lutz, Florida 33558 United States | |
| Phone | (800) 261 0281 |
| Website | trxadehealth.com |
Stock Details
| Ticker Symbol | MEDS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $6.50 |
| CIK Code | 0001382574 |
| CUSIP Number | 89846A207 |
| ISIN Number | US89846A4058 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Surendra K. Ajjarapu | Founder, Chairman, Chief Executive Officer and Secretary |
| Prashant Patel R.Ph. | Founder, President, Chief Operating Officer, Interim Chief Financial Officer, Interim Principal Financial and Accounting Officer and Director |
| Dr. Ramesh Kenchappa | Chief Scientific Officer |
| David M. Saslow Esq. | Inhouse Counsel |
| Jariel Morales | Executive Vice President |
| Dr. Shafaat Pirani Pharm.D. | Executive Vice President of Alliance Pharma Solutions, LLC |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2024 | 10-K | Annual Report |
| Apr 2, 2024 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
| Mar 6, 2024 | 8-K | Current Report |
| Feb 16, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Jan 17, 2024 | 8-K | Current Report |
| Jan 16, 2024 | 10-Q | Quarterly Report |
| Jan 11, 2024 | 8-K | Current Report |
| Nov 28, 2023 | 8-K | Current Report |
| Nov 21, 2023 | 8-K | Current Report |